Eli Lilly's most recent trend suggests a bullish bias. One trading opportunity on Eli Lilly is a Bull Put Spread using a strike $115.00 short put and a strike $110.00 long put offers a potential 15.74% return on risk over the next 3 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $115.00 by expiration. The full premium credit of $0.68 would be kept by the premium seller. The risk of $4.32 would be incurred if the stock dropped below the $110.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Eli Lilly is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Eli Lilly is bullish.
The RSI indicator is at 64.6 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Eli Lilly
Here's Why Eli Lilly Stock Surged 37% in 2018
Sun, 13 Jan 2019 23:01:00 +0000
The big pharma company made all the right moves in 2018.
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials
Sun, 13 Jan 2019 20:50:01 +0000
M&A momentum is building in the pharma space, with more deals announced last week, including Eli Lilly And Co (NYSE: LLY )'s $8-billion move to acquire Loxo Oncology Inc (NASDAQ: LOXO ). The following …
Here's Why Loxo Oncology Soared 66.4% in 2018, and Another 66% Since
Sun, 13 Jan 2019 11:30:00 +0000
The biopharma delivered the goods with its drug pipeline, scored marketing approval for its lead drug candidate, and agreed to be acquired for $8 billion.
5 Reasons Why Investors Should Buy Novo Nordisk (NVO) in 2019
Fri, 11 Jan 2019 22:36:10 +0000
Novo Nordisk (NVO) has a strong presence in the Diabetes care market and its top line is driven by strong performance of products like Victoza.
Stock Market Rally Runs Into Resistance; Boeing, GM, Macy's, American Airlines: Weekly Review
Fri, 11 Jan 2019 21:08:44 +0000
The stock market continued to run higher in the latest week, despite warnings from Macy's, American Airlines and Constellation Brands. GM and Boeing rallied on good news.
Also on Market Tamer…
Follow Us on Facebook